IQ4I Research & Consultancy published a new report on “Pharmaceutical Excipients Global Market – Forecast To 2022”

Excipients are inactive substances that modulate solubility, bioavailability and stability of active substances in a drug. Novel excipients are in great demand.

Pharmaceutical Excipients Global Market estimated to be worth $7,716 million by 2022”

— IQ4I Analyst

BOSTON , MASSACHUSETTS, U.S., April 26, 2018 /EINPresswire.com/ — Excipients are a broad range of non-active components combined with active pharmaceutical ingredient (API) during formulation to form a desired finished drug product and perform a wide range of functions. It is usually identified as a substance that aid to function API with better functionality such as bioavailability, stability, good taste, texture and patient acceptability with safety and efficacy of pharmaceuticals to improve the quality-of-life of the patient at a lower cost. In fact, a few decades ago, excipients were not considered important due to their inactive nature, but now they are considered as one of the essential components in the production of tablets, liquid orals, powders, semi-solids and parenteral as excipients impact the stabilization of drug product in various conditions such as change in pressure, temperature, pH etc. Oral (tablets and capsule) dosage forms are mostly preferred due to ease of manufacturing and patient compliance and the development of these oral dosage forms involves direct compression and granulation process. The majority of vertically integrated companies develop in-house excipients and small formulators often rely on external suppliers to outsource specialised co-processed functionality excipients.

Presently, there is demand for the development of novel excipients with technological advancements like new chemical entity excipients, new chemically modified grade excipients, existing excipients with the various route of administration and co-processed excipients. These novel excipients increase the scope for the development of new formulations and drug delivery system which is a major gain for the industry, but high cost and lengthy developmental process along with the safety and quality issues are delaying the excipients approval. Combination excipients are mostly preferred by the manufacturers as the single excipients do not meet all the functional requirements such as high solubility, stability and bioavailability. As estimated by IQ4I Research, the global pharmaceutical excipients market is expected to grow at mid range single digit CAGR to reach $7,716 million by 2022.

Development of highly soluble excipients for sustained and controlled release formulations, global pharmaceutical excipient outsourcing, manufacturing of co-processed excipients using nano- and liposome-mediated technologies, strategic partnership/alliance among excipient manufacturers are some of the factors driving pharmaceutical excipient market whereas less interest in developing novel excipients, contamination issues in formulations, and delay in approval of novel excipients are the factors restraining market growth. Recently in 2015, IPEC-Americas calls FDA to review process for novel excipients and create new regulations to relieve the uncertainties around the use of new excipients. The most commonly used excipients in the small molecule are carbohydrates, oleochemicals, petrochemicals, metallic oxides, silicates etc whereas in large molecules sodium salts, solvents, emulsifiers and amino acids etc are used.

The pharmaceutical excipients market is mainly classified into source/origin, material type, manufacturing process, functionality, application, finished products and geography. The pharmaceutical excipient source/origin market includes animal-, plant-, mineral- and synthetic-based excipients. By material type the pharmaceutical excipient is classified into inorganic chemicals, organic chemicals and others. Inorganic chemical segment divided into calcium salts, halites, metallic oxides, silicates and others. Likewise, organic chemicals are further divided into carbohydrates including sugar (actual sugar, sugar alcohol, artificial sweetener), starch (modified, converted, dried) and cellulose (cellulose ether, cellulose ester, croscarmellose sodium, microcrystalline cellulose), petrochemicals including glycol (polyethylene, propylene glycol), povidone, mineral hydrocarbons (petrolatum, mineral waxes, mineral oils), acrylic polymers, others (antimicrobials, antioxidants, dyes & lakes), oleochemicals including fatty alcohol, mineral stearate, glycerin and others (alcohol, citric acid, lactic acid, polysaccharide gums, Shellac), proteins including gelatin and others including water for injection and purified water.
The pharmaceutical excipients manufacturing process market includes granulation and direct compression. The pharmaceutical excipient by functionality is segmented into fillers & diluents, binders & adhesives, suspension & viscosity agents, coatings, colorants, flavoring agents & sweeteners, disintegrants, lubricants & glidants, preservatives, solvents, solubilizers and others (anti-adherents, buffering agents, chelating agents, compression aids, foam control agents, sorbents, antioxidants, gelling agents, emulsifiers, emollients & humectants and plasticizers).

The pharmaceutical excipients by the application is divided into oral formulations (tablets, capsules & liquids), topical, parenteral and advanced delivery system. By finished products, the excipient market is classified into prescription and over-the-counter.

Geographical wise, North America is the largest market followed by Europe, Asia and Rest of the World. The Asia Pacific region is the fastest growing region with a highest single digit CAGR from 2015 to 2022 suggesting an array of opportunities for growth and likely to be getting into the eyes of new investors in the pharmaceutical excipients market.

The pharmaceutical excipients global market is a highly fragmented market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the pharmaceutical excipient market are Ashland, Inc (U.S.), Associated British Foods Plc (U.K.), Avantor Performance Materials, Inc (U.S.), BASF SE (Germany), Croda International Plc (U.K.), Dow Chemical Company (U.S.), Evonik Industries AG (Germany), FMC Corporation (U.S.), Lubrizol Corporation (U.S.) and Roquette (France).

Mr. Satish Birudukota
IQ4I Research & Consultancy Pvt Ltd.,
+91-80-8147030229
email us here


Source: EIN Presswire

IQ4I Research & Consultancy published a report on Wound Closure & Advanced Wound Care Global Market – Forecast To 2023

Wound closure and advanced wound care devices are used for the closure of the wound. Increasing surgical procedures & chronic conditions are driving the market.

Wound Closure & Advanced Wound Care Global Market estimated to be worth $25,268.9 billion by 2023”

— IQ4I Analyst

BOSTON , MASSACHUSETTS, U.S., April 26, 2018 /EINPresswire.com/ — The wound is a breakdown in the protective function of the skin and loss of connectivity of epithelium by intentional or unintentional purpose that needs to be closed using different wound care products depending on the condition and span of the wound. Types of wound closure products like primary closure products are used in closure of fresh and acute wounds, whereas, secondary closure products are used in closure of chronic wounds. Primary wound care products are mainly used in surgical and trauma laceration applications and secondary wound care products in burns, ulcers, radionecrosis and others. These wound closure and advanced wound care products are mainly used in therapeutic procedures to avoid complications and enhance patient safety.

According to IQ4I analysis, the wound closure and advanced wound care global market is expected to reach $25,268.9 million by 2023. Increasing incidence of aging population and prevalence of lifestyle diseases, increase in surgical procedural volume, increase in prevalence of chronic wounds and government initiatives are some of the factors driving the wound closure and advanced wound care market. Demand for biologics, emergence of technically advanced products and acquisition to open an array of opportunities for market to flourish are some of the opportunities for wound closure and advanced wound care market. However, lack of trained professional in handling the sophisticated advanced wound care techniques, expensive sealants and glues impeding effective penetration in low and middle income countries are some of the factors hampering the market growth.

The wound closure and advanced wound care global market is mainly segmented by products, applications, end-users and by geography. The wound closure and advanced wound care global market by the product is segmented into primary wound closure and secondary wound closure. The primary wound closure product segment accounted for the largest share in 2016.
Based on applications, market is segmented into burns, ulcers, surgical wounds, trauma lacerations and radionecrosis. Ulcers are expected to grow at a strong CAGR from 2016-2023, due to increase in aging population and lifestyle diseases.

Among the various end users of the wound closure and advanced wound care market hospitals generated the largest revenue in 2016, due to usage of wide range of primary and secondary wound closure products which enhances patient safety thus driving the market growth rate.

Wound Healing Foundation (U.S.) along with the partnership with Wound Reach Foundation, that works with an aim of improving the quality of life for wound healing patients and their families through support of awareness, research and education has announced the research grant of $2,500 for the year 2017 to stimulate clinical research in wound healing.

Advancements in technology includes nanotechnology wound closure, skin substitutes, gene therapy, low level laser therapy, growth factors, Top closure 3S system, 3D printed skin for burn wounds, RECELL and various types of surgical sutures. One of the emerging trend in this market includes growth factors, these are the substances that are used to stimulate the growth and proliferation of the cells involved in wound healing and reduction of inflammation, these cells are secreted by the body and these factors influence the growth of wound healing cells by increasing their numbers, thus resulting in faster wound healing. Presently growth factors are most often used in patients with chronic and non-healing wounds such as chronic venous leg ulcers and diabetic foot ulcers. Cutimed Epiona developed by BSN Medical is a new VLU integrated solution that features a process of removing exudates and bacteria, reducing edema and preventing recurrence of chronic wounds. This product involves BSN’s DCC technology for infection management and it’s a type of native collagen that helps to rebuild the tissue.

Developed regions such as North America commanded the largest market share in 2016 due to high investments in healthcare infrastructures, availability of government funds improved market growth in this region. However, Asia-pacific region is expected to grow at the highest CAGR from 2016-2023 due to increased healthcare awareness, improved economic growth, and increasing awareness among the people about the impact of chronic wounds. Significant launch of new products, agreement, partnership, collaborations, and joint ventures are the industry trends that are playing a major role in the market growth.

Companies such as Acelity, Baxter International, 3M, Smith & Nephew and Johnson & Johnson that are ahead of other companies are considered to be leaders in this space with their marketed products and strong pipelines. Acelity and Smith & Nephew are leading in negative pressure wound therapy market while, Acelity and Organogenesis are major players in biological products. Some of the new and small entrants are trying to work on secondary wound closure products, as most of the established players are with primary wound closure products to achieve competitive advantage.
Emerging players of this market includes Organogenesis (U.S.), Kerecis (Iceland), Stratatech Corporation (U.S.), Nuo therapeutics (U.S.), Ackermann Instruments (Germany), The medicine company (U.S.), Derma Sciences (U.S.), Assut Medical Sarl (Switzerland), Dolphin Sutures (India).

Major players in the wound closure and advanced wound care global market Smith & Nephew (U.K.), Johnson and Johnson (U.S), Medtronic (Ireland), 3M healthcare (U.S), Acelity, Ltd. (U.S.), Coloplast (Denmark), C.R.Bard (U.S.), Baxter International (U.S.),Cardinal Health (U.S.), Integra life science (U.S.) and B. Braun Melsungen AG (Germany).

Mr. Satish Birudukota
IQ4I Research & Consultancy Pvt Ltd.,
+91-80-8147030229
email us here


Source: EIN Presswire

IQ4I Research & Consultancy published a new report on Next-Generation Sequencing (NGS) Global Market – Forecast To 2022

Sequencing technology has come a long way from the time of introduction of NGS that has revolutionized the way the human genomes are being sequenced.

Next-generation Sequencing (NGS) Global Market estimated to be worth $14,722.5 million by 2022”

— IQ4I Analyst

BOSTON , MASSACHUSETTS, U.S., April 26, 2018 /EINPresswire.com/ — Next-generation sequencing refers to modern non-Sanger-based high-throughput DNA sequencing technologies that can sequence millions or billions of DNA strands in parallel, yielding substantially more throughput and minimizing the need for the time consuming fragment-cloning methods that are often used in Sanger sequencing of genomes. Next-generation sequencing market is a fast emerging market with a high growth rate, as estimated by IQ4I Research that the Next-generation sequencing global market are expected to grow at a high double-digit CAGR from 2015-2022.
Reduced cost and high speed of NGS technology, increased usage in the clinical segment, new application areas of NGS and switch over from microarrays to NGS, are expected to propel the growth of next-generation sequencing market. However some issues like standardization of NGS for clinical use, complexity in data interpretation, shortage of skilled labor and dependence on grants and funding for NGS infrastructure may hinder the growth of next-generation sequencing market.

The Next-generation sequencing global market by technology is segmented into Reversible terminator sequencing, Ion semi-conductor sequencing, Sequencing by Ligation (SBL), Single-Molecule Real-time (SMRT) Sequencing and others. The Reversible terminator sequencing occupied highest market in Next-generation sequencing technology market. The Next-generation sequencing global market by products is segmented into Instruments, Services and Work-flow products. The services market is further segmented into Data analysis services and Sequencing Services. The Services segment is estimated to grow at strong CAGR from 2015 to 2022.

The Next-generation sequencing global market by Application is segmented based on process and field of application. By process, the market is segmented into Genomics, Epigenomics, Transcriptomics and others. Genomics application is further segmented into Whole genome sequencing, Exome sequencing, Targeted sequencing and De Novo sequencing). Epigenomics market is further segmented into ChiP sequencing and Methylation sequencing). By field of application, the market is segmented into Diagnostics, Drug discovery and development, Biomarker discovery, Agriculture and animal research and others. Diagnostics application is further segmented into Cancer diagnostics, Infectious disease diagnostics, Genetic analysis and Transplantation diagnostics. The Diagnostics application occupied highest market in Next-generation sequencing application market. The End-users consists of Academic Research, Hospitals and clinics, Biotech/Pharmaceuticals and Others. The Academic Research contributed the largest revenue as per estimates of IQ4I Research.

The Next-generation sequencing global market based on geography is divided into North America, Europe, Asia-Pacific and Rest of the world. North American region commanded the largest revenue in 2015 due to advanced technological healthcare framework, rise in growth of personalized medicine, increasing incidence of infectious disease and cancer, high R&D investment for genomic and proteomic sequence determination for biomarker and drug discovery research.
Some of the prominent players in next-generation sequencing market include Agilent Technologies (U.S.), BGI (China), Illumina, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Qiagen N.V. (Netherlands), Oxford Nanopore Technologies Ltd. (U.K.), Eurofins Scientific (U.K.), Roche holdings AG (Switzerland), DNASTAR, Inc. (U.S.), Thermo Fischer Scientific, Inc.(U.S).

Mr. Satish Birudukota
IQ4I Research & Consultancy Pvt Ltd.,
+91-80-8147030229
email us here


Source: EIN Presswire

Schiz Life's Most Popular Articles

BOSTON, MASSACHUSETTS, UNITED STATES, April 26, 2018 /EINPresswire.com/ — When it comes to comprehensive information on schizophrenia and all that pertains to it, Schiz Life is the place to go. Its extensive database has grown tremendously since its initial launch and will carry on doing the same in the years to come. Of course, all this has been made possible through the incredible involvement of the community.

Schiz Life has done incredible work in the mental health community, as it managed to single-handedly dispel many negative stereotypes relating to disorders of the mind. It did so by educating the population on the most sensitive topics in the field. Here are the website’s three most popular articles so far in 2018 that stand as living proof of that.

1. Borderline Schizophrenia 101 – Definition, Symptoms, Diagnosis
Even though the latest review of the Diagnostic and Statistical Manual of Mental Disorders established a universal diagnosis of the illness, there are many variations to schizophrenia. SchizLife’s popular article on borderline schizophrenia explores one of the most severely misunderstood facets of the condition.

Although it has never made it to the DSM as a standalone diagnosis, borderline schizophrenia is something that many patients struggle with. This entry offers some much-needed exposure to the topic, thus helping those in need of more information educate themselves.

2. The Stages of Schizophrenia
Anyone who’s struggled with the ups and downs of mental illness knows that one does not simply wake up without their sanity one morning. Just like other conditions, schizophrenia develops over time, and SchizLife.com’s well-read piece on the topic sheds some light on the onset of the disorder and its stages.

It is a valuable resource for anyone dealing with the diagnosis, as well as for those close to them. Schizophrenia is a complex disorder that can take on a diverse symptomatology depending on the moment in time, which is why having a proper understanding of it is crucial.

3. Famous People and Celebrities with Schizophrenia
Just because a person is a celebrity, that does not mean that they are exempt from the plight of mental illness. According to the article published on www.schizlife.com, plenty of famous people from all walks of life were battling schizophrenia, either publicly or behind closed doors. These individuals activated in countless fields, such as art, literature, music, science or sports.

The most notable name on the list certainly has to be that of Nobel prize laureate mathematician John Nash, whose life inspired the famous biopic A Beautiful Mind. Other global personalities who suffered from the condition include Beat generation novelist Jack Kerouac, male ballet dancer Vaslav Nijinsky, musician Jim Gordon and the illustrious Vincent Van Gogh.

About Schiz Life
Schiz Life is more than just a database containing information on the many facets of schizophrenia. It is a platform devoted to eradicating the stigma surrounding mental illness and taking schizophrenia off the list of taboo topics. Thus, its aim is to educate the population and clarify aspects regarding this sensitive discussion in any way possible.

In their view, struggling with a mental disorder as debilitating as schizophrenia is a challenging experience in itself. Thus, the last thing anyone needs is constant judgment from others. The only way to prevent it is by facilitating the public’s access to coherent and structured information, which is something Schiz Life does proudly.

Naturally, the project wouldn’t have been possible without the involvement of the mental health awareness and advocacy community. Thus, the website is always growing based on suggestions provided to webmasters by its devoted readership. After all, their enthusiasm for knowledge is what has kept the entire thing afloat all this time.

Alex Moore
Job Application Center
5356455443
email us here


Source: EIN Presswire

Rhode Island Mesothelioma Victims Center Now Urges a Maritime Worker with Mesothelioma in Rhode Island to Call for Direct Access to the Nation's Top Lawyers for a Much Better Compensation Settlement

The last thing we want to see happen to any type of maritime worker or Navy Veteran with mesothelioma in Rhode Island is for them to get shortchanged on financial compensation”

— Rhode Island Mesothelioma Victims Center

NEW YORK, NEW YORK, USA, April 26, 2018 /EINPresswire.com/ — The Rhode Island Mesothelioma Victims Center says, "There is no such thing as a 'federally sponsored mesothelioma compensation claims center' and if you are a maritime worker or Navy Veteran with mesothelioma in Rhode Island please call us anytime at 800-714-0303 so you do not get shortchanged on the compensation that you deserve. We are specifically talking about members of the merchant marine, shipyard workers, tug or barge operators, commercial fishermen, dock workers, maritime mechanics, deck hands or Navy Veterans with mesothelioma in Rhode Island.

"The last thing we want to see happen to any type of maritime worker or Navy Veteran with mesothelioma in Rhode Island is for them to get shortchanged on financial compensation because they hired a less-than-qualified local personal injury law firm." http://RhodeIsland.MesotheliomaVictimsCenter.Com

The group is urging the wife or the adult son or daughter of a maritime worker or Navy Veteran in Rhode Island who has recently been diagnosed with mesothelioma to call them anytime at 800-714-0303 to make certain they are dealing directly with the nation's most skilled and experienced mesothelioma attorneys as opposed to a local car accident law firm. "If you want the very best mesothelioma compensation, and a maritime worker in Rhode Island or the US Navy is involved, please call us anytime at 800-714-0303 and we will guarantee you are talking directly to the top mesothelioma attorneys in the United States-who get the best possible financial compensation results for their clients." http://RhodeIsland.MesotheliomaVictimsCenter.Com

For the best possible mesothelioma treatment options in Rhode Island the Rhode Island Mesothelioma Victims Center strongly recommends the following heath care facility with the offer to help a diagnosed victim, or their family get to the right physicians at this hospital. The Massachusetts General Hospital: http://www.massgeneral.org/.

According to the US Center for Disease Control the average age for a diagnosed victim of mesothelioma is 72 years old. Frequently victims of mesothelioma are initially misdiagnosed with pneumonia. This year between 2500, and 3000 US citizens will be diagnosed with mesothelioma. Mesothelioma is attributable to exposure to asbestos.

According to the CDC the states indicated with the highest incidence of mesothelioma include Maine, Massachusetts, Connecticut, Maryland, New Jersey, Pennsylvania, Ohio, West Virginia, Virginia, Michigan, Illinois, Minnesota, Louisiana, Washington, and Oregon. Mesothelioma also happens in Rhode Island.

High-risk work groups for exposure to asbestos in Rhode Island include US Navy Veterans, power plant workers, shipyard workers, maritime workers, oil refinery workers, industrial workers, plumbers, electricians, auto mechanics, machinists, or construction workers. Typically, the exposure to asbestos occurred in the 1950’s, 1960’s, 1970’s, or 1980’s.http://RhodeIsland.MesotheliomaVictimsCenter.Com

The Rhode Island Mesothelioma Victims Center says, “Before you hire a mesothelioma attorney please call us at 800-714-0303 and compare the qualifications of who we consider to be the nation’s most skilled mesothelioma attorneys to any other lawyer, or law firm. When it comes to obtaining the best mesothelioma settlement, the quality of the attorney matters, as we would like to explain.” http://RhodeIsland.MesotheliomaVictimsCenter.Com

For information about US Navy submarines, aircraft carriers and other types of navy ships please visit their website on this topic: http://www.navy.mil/navydata/our_ships.asp

For more information about mesothelioma please refer to the National Institutes of Health’s web site related to this rare form of cancer: https://www.cancer.gov/types/mesothelioma.

Michael Thomas
Rhode Island Mesothelioma Victims Center
800-714-0303
email us here


Source: EIN Presswire

Gene Synthesis 2018 Global Market Outlook,Research,Trends and Forecast to 2022

WiseGuyReports.Com Publish a New Market Research Report On –“ Gene Synthesis 2018 Global Market Outlook,Research,Trends and Forecast to 2022”.

PUNE, INDIA, April 26, 2018 /EINPresswire.com/ —
Description:

Gene synthesis refers to chemically synthesizing a strand of DNA base-by-base. Unlike DNA replication that occurs in cells or by Polymerase Chain Reaction (PCR), gene synthesis does not require a template strand. Rather, gene synthesis involves the step-wise addition of nucleotides to a single-stranded molecule, which then serves as a template for creation of a complementary strand. Gene synthesis is the fundamental technology upon which the field of synthetic biology has been built.

The report of “Global Gene Synthesis Market by Manufacturers, Countries, Type and Application, Forecast to 2022” is a professional and in-depth study on the current state of the Gene Synthesis market. Annual estimates and forecasts are provided for the period 2017 through 2022. Also, a six-year historic analysis is provided for these markets. The global market for Gene Synthesis is expected to reach about 410 million USD by 2022 from 202 million USD in 2017, registering a compounded annual growth rate (CAGR) of 12.5 % during the analysis period, 2017-2022.

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/1153181-global-gene-synthesis-market-by-manufacturers-countries-type-and-application-forecast

For more information or any query mail at sales@wiseguyreports.com

Scope of the Report:
This report focuses on the Gene Synthesis in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturer, this report covers
Genescript
GeneArt (Thermofischer)
IDT
DNA 2.0 (ATUM)
OriGene
BBI
Genewiz
Eurofins Genomics
Gene Oracle
SBS Genetech
Bio Basic

Market Segment by Region, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina)
Middle East and Africa (Egypt, South Africa)

Market Segment by Type, covers
Below?1000?bp
1001?-?3000?bp
3001-?5000?bp
Above?5000?bp

Market Segment by Application, can be divided into
Commercial
Academic Research

There are 15 chapters to deeply display the global Gene Synthesis market.

Chapter 1, to describe Gene Synthesis Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Gene Synthesis, with sales, revenue, and price of Gene Synthesis, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Gene Synthesis, for each region, from 2012 to 2017;

Continue…..

Table Of Contents – Major Key Points

1 Market Overview 1
1.1 Gene Synthesis Introduction 1
1.2 Market Analysis by Type 2
1.2.1 Below 1000 bp 3
1.2.2 1001 – 3000 bp 4
1.2.3 3001- 5000 bp 5
1.2.4 Above 5000 bp 6
1.3 Market Analysis by Applications 7
1.3.1 Academic Research 7
1.3.2 Commercial 8
1.4 Market Analysis by Regions 9
1.4.1 North America (USA, Canada and Mexico) 9
1.4.1.1 USA Market States and Outlook (2012-2017) 9
1.4.1.2 Canada Market States and Outlook (2012-2017) 10
1.4.1.3 Mexico Market States and Outlook (2012-2017) 10
1.4.2 Europe (Germany, France, UK, Russia and Italy) 11
1.4.2.1 Germany Market States and Outlook (2012-2017) 11
1.4.2.2 France Market States and Outlook (2012-2017) 12
1.4.2.3 UK Market States and Outlook (2012-2017) 12
1.4.2.4 Russia Market States and Outlook (2012-2017) 13
1.4.2.5 Italy Market States and Outlook (2012-2017) 13
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 14
1.4.3.1 China Market States and Outlook (2012-2017) 14
1.4.3.2 Japan Market States and Outlook (2012-2017) 15
1.4.3.3 Korea Market States and Outlook (2012-2017) 15
1.4.3.4 India Market States and Outlook (2012-2017) 16
1.4.3.5 Southeast Asia Market States and Outlook (2012-2017) 16
1.4.4 South America 17
1.4.4.1 Brazil Market States and Outlook (2012-2017) 17
1.4.4.2 Argentina Market States and Outlook (2012-2017) 18
1.4.5 Middle East and Africa 19
1.4.5.1 Egypt Market States and Outlook (2012-2017) 19
1.4.5.2 South Africa Market States and Outlook (2012-2017) 20
1.5 Market Dynamics and News 20
1.5.1 Market Drivers and Opportunities 20
1.5.2 Market Driving Force 21
1.5.3 Industry News Analysis of Gene Synthesis 21

2 Analysis of Gene Synthesis Industry Key Manufacturers 23
2.1 Genescript 23
2.1.1 Company Profile 23
2.1.2 Product Information 24
2.1.3 Sales, Price, Revenue and Gross Margin 25
2.2 GeneArt (Thermofischer) 26
2.2.1 Company Profile 26
2.2.2 Product Information 27
2.2.3 Sales, Price, Revenue and Gross Margin 27
2.3 IDT 28
2.3.1 Company Profile 28
2.3.2 Product Information 29
2.3.3 Sales, Price, Revenue and Gross Margin 29
2.4 DNA 2.0 (ATUM) 30
2.4.1 Company Profile 30
2.4.2 Product Information 31
2.4.3 Sales, Price, Revenue and Gross Margin 31
2.5 OriGene 32
2.5.1 Company Profile 32
2.5.2 Product Information 33
2.5.3 Sales, Price, Revenue and Gross Margin 34
2.6 BBI 35
2.6.1 Company Profile 35
2.6.2 Product Information 36
2.6.3 Sales, Price, Revenue and Gross Margin 36
2.7 Genewiz 37
2.7.1 Company Profile 37
2.7.2 Product Information 38
2.7.3 Sales, Price, Revenue and Gross Margin 38
2.8 Eurofins Genomics 39
2.8.1 Company Profile 39
2.8.2 Product Information 40
2.8.3 Sales, Price, Revenue and Gross Margin 41

Continue…..

Report Details @ https://www.wiseguyreports.com/reports/1153181-global-gene-synthesis-market-by-manufacturers-countries-type-and-application-forecast

For more information or any query mail at sales@wiseguyreports.com

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global Breast X-ray Machine Market 2018 – Industry Analysis, Size, Share, Strategies and Forecast to 2025

PUNE, MAHARASHTRA, INDIA, April 26, 2018 /EINPresswire.com/ — Global Breast X-ray Machine Industry

New Study on “2018-2025 Breast X-ray Machine Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” added to Wise Guy Reports Database

This report studies the global Breast X-ray Machine market status and forecast, categorizes the global Breast X-ray Machine market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

The major manufacturers covered in this report 
HOLOGIC 
Planmed 
GE 
SINO MDT 
BASDA 
SMEW 
PERLONG 
DANDONG KANGJIA 
AHGELL TECHNOLOGY 
HU.Q 
Sedecal 
Simens 
Radlink 
KANGYUAN 
XRAY

Try Sample Report @   https://www.wiseguyreports.com/sample-request/3141439-global-breast-x-ray-machine-market-research-report-2018

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering 
North America 
Europe 
Asia-Pacific 
South America 
Middle East & Africa

The regional scope of the study is as follows: 
North America 
United States 
Canada 
Mexico 
Asia-Pacific 
China 
India 
Japan 
South Korea 
Australia 
Indonesia 
Singapore 
Rest of Asia-Pacific 
Europe 
Germany 
France 
UK 
Italy 
Spain 
Russia 
Rest of Europe 
Central & South America 
Brazil 
Argentina 
Rest of South America 
Middle East & Africa 
Saudi Arabia 
Turkey 
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into 
Diagnostic X-Ray Machine 
Treatment Of X-Ray Machine 
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including 
Hospital 
Clinic 
Physical Examination Center

The study objectives of this report are: 
To analyze and study the global Breast X-ray Machine sales, value, status (2013-2017) and forecast (2018-2025). 
Focuses on the key Breast X-ray Machine manufacturers, to study the sales, value, market share and development plans in future. 
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis. 
To define, describe and forecast the market by type, application and region. 
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks. 
To identify significant trends and factors driving or inhibiting the market growth. 
To analyze the opportunities in the market for stakeholders by identifying the high growth segments. 
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market 
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market 
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Breast X-ray Machine are as follows: 
History Year: 2013-2017 
Base Year: 2017 
Estimated Year: 2018 
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders 
Breast X-ray Machine Manufacturers 
Breast X-ray Machine Distributors/Traders/Wholesalers 
Breast X-ray Machine Subcomponent Manufacturers 
Industry Association 
Downstream Vendors

Available Customizations 
following customization options are available for the report: 
Regional and country-level analysis of the Breast X-ray Machine market, by end-use. 
Detailed analysis and profiles of additional market players.

Some points from table of content:

Global Breast X-ray Machine Market Research Report 2018 
1 Breast X-ray Machine Market Overview 
1.1 Product Overview and Scope of Breast X-ray Machine 
1.2 Breast X-ray Machine Segment by Type (Product Category) 
1.2.1 Global Breast X-ray Machine Production and CAGR (%) Comparison by Type (Product Category)(2013-2025) 
1.2.2 Global Breast X-ray Machine Production Market Share by Type (Product Category) in 2017 
1.2.3 Diagnostic X-Ray Machine 
1.2.4 Treatment Of X-Ray Machine 
1.3 Global Breast X-ray Machine Segment by Application 
1.3.1 Breast X-ray Machine Consumption (Sales) Comparison by Application (2013-2025) 
1.3.2 Hospital 
1.3.3 Clinic 
1.3.4 Physical Examination Center 
1.4 Global Breast X-ray Machine Market by Region (2013-2025) 
1.4.1 Global Breast X-ray Machine Market Size (Value) and CAGR (%) Comparison by Region (2013-2025) 
1.4.2 North America Status and Prospect (2013-2025) 
1.4.3 Europe Status and Prospect (2013-2025) 
1.4.4 Asia-Pacific Status and Prospect (2013-2025) 
1.4.5 South America Status and Prospect (2013-2025) 
1.4.6 Middle East & Africa Status and Prospect (2013-2025) 
1.5 Global Market Size (Value) of Breast X-ray Machine (2013-2025) 
1.5.1 Global Breast X-ray Machine Revenue Status and Outlook (2013-2025) 
1.5.2 Global Breast X-ray Machine Capacity, Production Status and Outlook (2013-2025)

2 Global Breast X-ray Machine Market Competition by Manufacturers 
2.1 Global Breast X-ray Machine Capacity, Production and Share by Manufacturers (2013-2018) 
2.1.1 Global Breast X-ray Machine Capacity and Share by Manufacturers (2013-2018) 
2.1.2 Global Breast X-ray Machine Production and Share by Manufacturers (2013-2018) 
2.2 Global Breast X-ray Machine Revenue and Share by Manufacturers (2013-2018) 
2.3 Global Breast X-ray Machine Average Price by Manufacturers (2013-2018) 
2.4 Manufacturers Breast X-ray Machine Manufacturing Base Distribution, Sales Area and Product Type 
2.5 Breast X-ray Machine Market Competitive Situation and Trends 
2.5.1 Breast X-ray Machine Market Concentration Rate 
2.5.2 Breast X-ray Machine Market Share of Top 3 and Top 5 Manufacturers 
2.5.3 Mergers & Acquisitions, Expansion

For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/3141439-global-breast-x-ray-machine-market-research-report-2018

3 Global Breast X-ray Machine Capacity, Production, Revenue (Value) by Region (2013-2018) 
3.1 Global Breast X-ray Machine Capacity and Market Share by Region (2013-2018) 
3.2 Global Breast X-ray Machine Production and Market Share by Region (2013-2018) 
3.3 Global Breast X-ray Machine Revenue (Value) and Market Share by Region (2013-2018) 
3.4 Global Breast X-ray Machine Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
3.5 North America Breast X-ray Machine Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
3.6 Europe Breast X-ray Machine Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
3.7 Asia-Pacific Breast X-ray Machine Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
3.8 South America Breast X-ray Machine Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
3.9 Middle East & Africa Breast X-ray Machine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global Polyurea Market 2018 – Industry Analysis, Size, Share, Strategies and Forecast to 2025

PUNE, MAHARASHTRA, INDIA, April 26, 2018 /EINPresswire.com/ — Global Polyurea Industry

New Study on “2018-2025 Polyurea Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” added to Wise Guy Reports Database

The major manufacturers covered in this report 
BASF 
Covestro 
Huntsman 
PPG Industries 
The Sherwin-Williams 
Advanced Polymer Solutions 
APV Engineered Coatings 
Convertec 
Dinsmore Welding & Fabrication 
Geoliz Waterproofers 
Hutchinson Manufacturing 
NATIONWIDE PROTECTIVE COATING 
Paramount Metal Finishing 
POLYCOAT PRODUCTS 
Quaker Chemical 
Rhino Linings 
Scorpion Protection Coatings 
Wilko Retail 
VersaFlex 

Try Sample Report @   https://www.wiseguyreports.com/sample-request/3141458-global-polyurea-market-research-report-2018

This report studies the global Polyurea market status and forecast, categorizes the global Polyurea market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China and other regions (India, Southeast Asia, Central & South America, and Middle East & Africa).

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering 

North America 
Europe 
China 
Japan 
Other Regions (India, Southeast Asia, Central & South America and Middle East & Africa)

The regional scope of the study is as follows: 
North America 
United States 
Canada 
Mexico 
Asia-Pacific 
China 
India 
Japan 
South Korea 
Australia 
Indonesia 
Singapore 
Rest of Asia-Pacific 
Europe 
Germany 
France 
UK 
Italy 
Spain 
Russia 
Rest of Europe 
Central & South America 
Brazil 
Argentina 
Rest of South America 
Middle East & Africa 
Saudi Arabia 
Turkey 
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into 
Pure Polyurea 
Half Polyurea 
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including 
Chemical 
Building 
Tunnel 
Bridge 
Other

The study objectives of this report are: 
To analyze and study the global Polyurea capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025); 
Focuses on the key Polyurea manufacturers, to study the capacity, production, value, market share and development plans in future. 
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis. 
To define, describe and forecast the market by type, application and region. 
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks. 
To identify significant trends and factors driving or inhibiting the market growth. 
To analyze the opportunities in the market for stakeholders by identifying the high growth segments. 
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market 
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market 
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Polyurea are as follows: 
History Year: 2013-2017 
Base Year: 2017 
Estimated Year: 2018 
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders 
Polyurea Manufacturers 
Polyurea Distributors/Traders/Wholesalers 
Polyurea Subcomponent Manufacturers 
Industry Association 
Downstream Vendors

Available Customizations 
following customization options are available for the report: 
Regional and country-level analysis of the Polyurea market, by end-use. 
Detailed analysis and profiles of additional market players.

Some points from table of content:

Global Polyurea Market Research Report 2018 
1 Polyurea Market Overview 
1.1 Product Overview and Scope of Polyurea 
1.2 Polyurea Segment by Type (Product Category) 
1.2.1 Global Polyurea Production and CAGR (%) Comparison by Type (Product Category)(2013-2025) 
1.2.2 Global Polyurea Production Market Share by Type (Product Category) in 2017 
1.2.3 Pure Polyurea 
1.2.4 Half Polyurea 
1.3 Global Polyurea Segment by Application 
1.3.1 Polyurea Consumption (Sales) Comparison by Application (2013-2025) 
1.3.2 Chemical 
1.3.3 Building 
1.3.4 Tunnel 
1.3.5 Bridge 
1.3.6 Other 
1.4 Global Polyurea Market by Region (2013-2025) 
1.4.1 Global Polyurea Market Size (Value) and CAGR (%) Comparison by Region (2013-2025) 
1.4.2 North America Status and Prospect (2013-2025) 
1.4.3 Europe Status and Prospect (2013-2025) 
1.4.4 China Status and Prospect (2013-2025) 
1.4.5 Japan Status and Prospect (2013-2025) 
1.5 Global Market Size (Value) of Polyurea (2013-2025) 
1.5.1 Global Polyurea Revenue Status and Outlook (2013-2025) 
1.5.2 Global Polyurea Capacity, Production Status and Outlook (2013-2025)

For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/3141458-global-polyurea-market-research-report-2018

2 Global Polyurea Market Competition by Manufacturers 
2.1 Global Polyurea Capacity, Production and Share by Manufacturers (2013-2018) 
2.1.1 Global Polyurea Capacity and Share by Manufacturers (2013-2018) 
2.1.2 Global Polyurea Production and Share by Manufacturers (2013-2018) 
2.2 Global Polyurea Revenue and Share by Manufacturers (2013-2018) 
2.3 Global Polyurea Average Price by Manufacturers (2013-2018) 
2.4 Manufacturers Polyurea Manufacturing Base Distribution, Sales Area and Product Type 
2.5 Polyurea Market Competitive Situation and Trends 
2.5.1 Polyurea Market Concentration Rate 
2.5.2 Polyurea Market Share of Top 3 and Top 5 Manufacturers 
2.5.3 Mergers & Acquisitions, Expansion

3 Global Polyurea Capacity, Production, Revenue (Value) by Region (2013-2018) 
3.1 Global Polyurea Capacity and Market Share by Region (2013-2018) 
3.2 Global Polyurea Production and Market Share by Region (2013-2018) 
3.3 Global Polyurea Revenue (Value) and Market Share by Region (2013-2018) 
3.4 Global Polyurea Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
3.5 North America Polyurea Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
3.6 Europe Polyurea Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
3.7 China Polyurea Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
3.8 Japan Polyurea Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Polyurea Supply (Production), Consumption, Export, Import by Region (2013-2018) 
4.1 Global Polyurea Consumption by Region (2013-2018) 
4.2 North America Polyurea Production, Consumption, Export, Import (2013-2018) 
4.3 Europe Polyurea Production, Consumption, Export, Import (2013-2018) 
4.4 China Polyurea Production, Consumption, Export, Import (2013-2018) 
4.5 Japan Polyurea Production, Consumption, Export, Import (2013-2018) 
4.6 Southeast Asia Polyurea Production, Consumption, Export, Import (2013-2018) 
4.7 India Polyurea Production, Consumption, Export, Import (2013-2018) 
4.8 South America Polyurea Production, Consumption, Export, Import (2013-2018) 
4.9 Middle East and Africa Polyurea Production, Consumption, Export, Import (2013-2018)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Integral BioSystems Offers Services and Innovations at 2018 ARVO Annual Meeting in Honolulu, Hawaii April 29-May 3, 2018

Integral BioSystems LLC to display in Booth 933 at the ARVO Annual Meeting from April 29 to May 3, 2018, at the Hawaii Convention Center in Honolulu, Hawaii.

NanoM™ and OcuSurf™ are sure to be game-changers for improving drug efficacy and patient compliance”

— Dr. Shikha Barman

BEDFORD, MA, US, April 25, 2018 /EINPresswire.com/ — Integral BioSystems LLC, Boston area CRO specializing in ophthalmological pharmaceutical formulation development, will be in the spotlight as a participating exhibitor (Booth # 933) during the ARVO 2018 Annual Meeting of the Association for Research in Vision and Ophthalmology from April 29, 2018 to May 3, 2018, to be held at the Hawaii Convention Center in Honolulu, Hawaii.

With almost 40 years of combined experience in all phases of tissue targeted, sustained release pharmaceutical formulation development, the firm’s CEO and President, Dr. Shikha P. Barman and Head of R&D, Kevin Ward will be available to discuss the specific requirements of interested attendees. In addition, Integral BioSystems scientists will be presenting three posters based on its internal drug development programs, based on the company’s issued patents on its platform technologies at the following times and locations:

Sunday, April 29, 2018: Sustained Release of Small Hydrophilic Peptides to the Ocular Surface via NanoM™
Shikha Barman, Yang Li, Laura Kaminski, Chunhong Li and Kevin Ward
Poster ID 238-C0049; 8:30 AM-10:15 AM

Sunday, April 29, 2018: Development of a Highly Bioavailable, Sustained Release Nanocore-based (OcuSurf™) Ophthalmic Formulation for the Treatment of Blepharitis
Kevin Ward, Koushik Barman, Chunhong Li, Yugang Chen, Yang Li and Kevin Ward
Poster ID 230-C0041: 8:30 AM-10:15 AM

Thursday, May 3, 2018: A Bioavailable, Sustained Release Nanocore (OcuSurf™) Brinzolamide Drug Product for Glaucoma Therapy
Koushik Barman, Chunhong Li, Yugang Chen, Yang Li, Kevin Ward and Shikha Barman
Poster ID: 5690-A0409; 8:30 AM-10:15 AM

About the Symposium
The ARVO 2018 Annual Meeting of the Association for Research in Vision and Ophthalmology will cover subjects like Medicine, Eyesight, Vision, Ophthalmology, and Eye Health. This gathering of scientists, medical personnel, and representatives from related businesses combines a wide range of talks from commercial and academic figures in ophthalmological science, poster presentations about recent developments in ophthalmology, and offers of ophthalmology-related products and services. It is anticipated that nearly 11,000 people will participate in this Meeting.

About Integral BioSystems
Integral BioSystems is a specialty drug delivery contract research organization that offers an integrated, practical approach to formulation development projects for both small molecule and large molecule drug candidates. Offering contract services to pharmaceutical companies to develop drug products through its CMC offerings in analytical method development, formulation development, process development, scale-up and technology transfer, the company also partners with pharmaceutical companies to co-develop products based on its proprietary pharmaceutical delivery systems.

The Company has developed numerous dosage forms for ophthalmic applications. Integral BioSystems has a translational approach to drug development, customizing delivery systems to achieve the biologically effective objectives of the therapy. Dosage forms are customized to achieve sustained release or targeted, tissue-focused delivery or fast-release/instant delivery, depending upon the desired product attributes.

For those seeking to develop a formulation for a new drug substance, a 505b2 product or a generic drug product, Dr. Barman will be available to answer questions about the suitability of Integral’s recently patented drug delivery platform technologies, NanoM™ and OcuSurf™, for any desired application.

Dave Karasic
Integral BioSystems, LLC
6178208483
email us here


Source: EIN Presswire

Abudo Offers Exceptional Disease Specific Tools to Aid Health and Wellness Education

Abudo offers exceptional disease specific tools to aid health and wellness education

Abudo unveils its exceptionally informative tools on disease education and improved quality of life for patients, friends, family and coworkers.

PALO ALTO, CALIFORNIA, UNITED STATES, April 25, 2018 /EINPresswire.com/ — In “November 2017”, Abudo launched its online healthcare platform providing easy and structured disease education to patients, friends and family members. Abudo is an engaging, easy to digest video course provider, offering patients and their families a guideline to take control of their well-being by learning about illnesses, caregiving as well as health and security standards at workplace. Abudo has successfully debuted its first online course on HIV and AIDS, with the end goal to create awareness and improve quality of life. It aims to bring over 30 more, regarding wellness and disease education with a value addition of exceptionally informative and supporting disease specific tools to your doorstep.

“Our tools are the first of their kind, support documents prepared to aid online patient education”, claims Abudo’s CEO Tariq Khursheed. “We are an authentic and well-researched content provider, engaged in promoting 100% unbiased patient education online through our patient education website while our tools help you steer through your disease management effectively”

Abudo has more than 70k online health success education disseminators. The tools it provides are supportive worksheets, list of nutritionally valuable and invaluable foods along with guidelines that help a patient and caregiver understand disease management. The company’s vision reflects gaining a competitive edge by providing 100% unbiased and impartial health education through easy to acquire and learn from tools. Abudo talks about taboo subjects and emphasizes on debunking common misconceptions, myths and stigmas associated with diseases and provides valuable guidelines in the form of tools to support the information given. The courses offered are designed for the sole purpose of helping patients and their families understand and manage their illness. All of Abudo’s courses are online and are available 24/7. Interested individuals can simply sign up for a course and access it from their desktop or mobile any anywhere, at anytime with absolutely no age, gender or accessibility restriction. All of this for just $15 is definitely what makes this platform worth subscribing.

Abudo tools can help patients and caregivers retain missed information as well as utilize them as framework for effective disease management.

About Abudo:
Abudo is an online health success platform providing easy, structured disease education to patients, friends & family members. It believes in passion for creating a better life, by offering a variety of courses including both, communicable as well as non-communicable diseases along with a course completion certification at the end of each course. Abudo offers value adding guidelines and checklists to improve quality of life all while endeavoring to help patients and caregivers manage stress, improve lifestyle and lead a healthy life.

Kay Kendall
Abudo
+1-650-503-1188
email us here


Source: EIN Presswire